A report was released recently that sheds lots of light on the Implantable Cardiac Monitor Market. The report covers an overview of the industry along with a
The growing number of atrial fibrillation, myocardial infraction, and unhealthy lifestyle, as well as growing investment in the healthcare sector, have fueled the demand for cardiac monitoring
/PRNewswire/ Verified Market Research recently published a report, "Implantable Cardiac Monitor Market" By Indication Type (Cardiac Arrhythmias, Atrial.
United States (~89%), followed by Japan among the seven major markets.
Medtronic with its four ICM products is one of the market leaders in the arena. More recently, LINQ 2 cardiac monitor has received approval in Europe during the fourth quarter of the fiscal year 2020. Thereby, indicating the strong foothold of Medtronic in the market of ICM.
In June 2020 LUX-Dx an insertable cardiac monitor by
Boston Scientific has been approved by U.S. Food and Drug Administration. It is the first ICM device with remote programming paired with dual-stage arrhythmia detection algorithm. These devices are expected to grow the market.
On May 20, 2020,